Comparative Cardiac Risks of Methylphenidate and Amphetamines in Treatment of ADHD

Abstract

The risk for adverse cardiac events in subjects between 3 and 20 years of age treated with methylphenidate or amphetamine salts for ADHD was determined in a retrospective study at University of Florida, Gainesville, FL.

Keywords

• antidepressants
• bronchodilators
• congenital anomalies